Renal thromboembolism during treatment with recombinant activated factor VII (rFVIIa) in a child with hemophilia B with factor IX inhibitors

被引：0
|
作者：
Danko Milošević
Ernest Bilić
Danica Batinić
Mirjana Poropat
Ranka Štern-Padovan
Slobodan Galić
Daniel Turudić
机构：
[1] Clinical Medical Centre Zagreb,Department of Pediatrics, Division of Nephrology
[2] University of Zagreb School of Medicine,Department of Pediatrics, Division of Hematology and Oncology
[3] Clinical Medical Centre Zagreb,Department of Nuclear Medicine and Radiation Protection
[4] University of Zagreb School of Medicine School of Medicine,Department for Diagnostic and Interventional Radiology
[5] Clinical Medical Centre Zagreb,undefined
[6] University of Zagreb School of Medicine,undefined
[7] Clinical Medical Centre Zagreb,undefined
[8] University of Zagreb School of Medicine,undefined
[9] University of Zagreb School of Medicine,undefined
来源：
BMC Pediatrics | / 14卷
关键词：
Vascular Anomaly; Hemophilia Patient; Novoseven; rFVIIa Administration; Multiple Renal Artery;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] Safety and pharmacokinetics of subcutaneously administered recombinant activated factor VII (rFVIIa)
    Tiede, A.
    Friedrich, U.
    Stenmo, C.
    Allen, G.
    Giangrande, P.
    Goudemand, J.
    Hay, C.
    Holmstrom, M.
    Klamroth, R.
    Lethagen, S.
    McKenzie, S.
    Miesbach, W.
    Negrier, C.
    Yuste, V. J.
    Berntorp, E.
    [J]. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2011, 9 (06) : 1191 - 1199
  • [32] Factor IX inhibitors and anaphylaxis in hemophilia B
    Warrier, I
    Ewenstein, BM
    Koerper, MA
    Shapiro, A
    Key, N
    DiMichele, D
    Miller, RT
    Pasi, J
    Rivard, GE
    Sommer, SS
    Katz, J
    Bergmann, F
    Ljung, R
    Petrini, P
    Lusher, JM
    [J]. JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 1997, 19 (01) : 23 - 27
  • [33] Immune tolerance induction: a role for recombinant activated factor VII (rFVIIa)?
    Brackmann, HH
    Effenberger, W
    Hess, L
    Schwaab, R
    Oldenburg, J
    [J]. EUROPEAN JOURNAL OF HAEMATOLOGY, 1998, 61 : 18 - 23
  • [34] Severe obstetric bleeding treated with recombinant activated factor VII (rFVIIa)
    Segal, S
    Shemesh, IY
    Blumental, R
    Yoffe, B
    Laufer, N
    Ezra, Y
    Levy, I
    Mazor, M
    Martinowitz, U
    [J]. 2ND WORLD CONGRESS ON CONTROVERSIES IN OBSTETRICS, GYNECOLOGY & INFERTILITY, 2001, : 43 - 46
  • [35] Recombinant activated factor VII (rFVIIa): Characterization, manufacturing, and clinical development
    Jurlander, B
    Thim, L
    Klausen, NK
    Persson, E
    Kjalke, M
    Rexen, P
    Jorgensen, TB
    Ostergaard, PB
    Erhardtsen, E
    Bjorn, SE
    [J]. SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2001, 27 (04): : 373 - 383
  • [36] Control of a persistent obstetric haemorrhage with activated recombinant factor VII (rFVIIA)
    Jakobsen, DJ
    Shemesh, IY
    Boksenbojm, PM
    Blumenntal, R
    Segal, S
    Yoffe, B
    Martinovitz, U
    [J]. INTENSIVE CARE MEDICINE, 2001, 27 : S173 - S173
  • [37] Single-dose recombinant activated factor VII therapy in hemophilia patients with inhibitors
    Kenet, Gili
    Martinowitz, Uri
    [J]. SEMINARS IN HEMATOLOGY, 2008, 45 (02) : S38 - S41
  • [38] Recombinant factor VIIa for patients with inhibitors to factor VIII or IX or factor VII deficiency
    Scharrer, I
    [J]. HAEMOPHILIA, 1999, 5 (04) : 253 - 259
  • [39] Recombinant Activated Factor VII (rFVIIa) Dosing and Efficacy in the Treatment of Cranial Hemorrhage in Hemophilia Patients with Inhibitors: An Analysis of the Hemophilia and Thrombosis Research Society Registry (HTRS) (2004-2008)
    Nakar, Charles T.
    Cooper, David L.
    DiMichele, Donna
    [J]. BLOOD, 2008, 112 (11) : 794 - 795
  • [40] Spontaneous intracranial hemorrhage due to congenital factor VII deficiency in two term siblings: Treatment with activated recombinant factor VII (rFVIIa)
    Salameh, MM
    Banda, RW
    ElAli, M
    [J]. THROMBOSIS AND HAEMOSTASIS, 1997, : PS47 - PS47
12345